Phase II clinical trial - Recherches "plusieurs pathologies"

Recherches "plusieurs pathologies"
Ouvert depuis le: 12.08.2021
Site: Paris
Public cible
My Own Specific Treatment : A two-period, multicenter, randomized, open-label, phase II study evaluating the clinical benefit of a maintenance treatment targeting tumor molecular alterations in patients with progressive locally-advanced or metastatic solid tumors
Description de l'essai

This trial evaluates the efficacy of 4 oral targeted therapies (everolimus, sorafenib, pazopanib, and nilotinib) in patients with any kind of cancer whose harbour the matching targets of these drugs.